SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-022060
Filing Date
2021-06-04
Accepted
2021-06-04 16:46:45
Documents
1
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3775
  Complete submission text file 0000899243-21-022060.txt   5545
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Reporting) CIK: 0000310158 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40235 | Film No.: 21997082
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 (908) 740-4000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

IRS No.: 852269702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences